Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 2
1946 4
1947 5
1948 2
1951 1
1952 3
1956 2
1958 3
1959 1
1960 1
1961 1
1962 2
1963 1
1964 1
1965 5
1966 1
1967 6
1968 1
1969 6
1970 2
1971 13
1972 3
1973 5
1974 5
1975 7
1976 4
1977 8
1978 7
1979 5
1980 2
1981 5
1982 3
1983 2
1984 4
1985 9
1986 11
1987 5
1988 7
1989 4
1990 7
1991 2
1992 4
1993 11
1994 8
1995 6
1996 5
1997 2
1998 11
1999 8
2000 15
2001 13
2002 8
2003 10
2004 20
2005 18
2006 13
2007 23
2008 29
2009 22
2010 22
2011 30
2012 29
2013 31
2014 36
2015 48
2016 43
2017 32
2018 42
2019 59
2020 65
2021 75
2022 55
2023 48
2024 65
2025 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

995 results

Results by year

Filters applied: . Clear all
Page 1
Project Introduction.
Nelson J, Jones V. Nelson J, et al. Among authors: jones v. AIDS Patient Care STDS. 2022 Nov;36(S2):87-91. doi: 10.1089/apc.2022.0101. AIDS Patient Care STDS. 2022. PMID: 36178403 Free article. No abstract available.
Infectious Disease.
Porter E, Lutchmun W, Smethurst HB, Jones V. Porter E, et al. Among authors: jones v. Clin Exp Dermatol. 2025 May 30:llaf241. doi: 10.1093/ced/llaf241. Online ahead of print. Clin Exp Dermatol. 2025. PMID: 40444371 No abstract available.
Physicians and Disabilities.
Jones V, Dryer B. Jones V, et al. Mo Med. 2025 May-Jun;122(3):215-220. Mo Med. 2025. PMID: 40747399 Free PMC article.
Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.
Norton ES, Whaley LA, Jones VK, Brooks MM, Russo MN, Morderer D, Jessen E, Schiapparelli P, Ramos-Fresnedo A, Zarco N, Carrano A, Rossoll W, Asmann YW, Lam TT, Chaichana KL, Anastasiadis PZ, Quiñones-Hinojosa A, Guerrero-Cázares H. Norton ES, et al. Among authors: jones vk. Sci Adv. 2024 Aug 9;10(32):eadn1607. doi: 10.1126/sciadv.adn1607. Epub 2024 Aug 7. Sci Adv. 2024. PMID: 39110807 Free PMC article.
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Lewis G, Duffy L, Ades A, Amos R, Araya R, Brabyn S, Button KS, Churchill R, Derrick C, Dowrick C, Gilbody S, Fawsitt C, Hollingworth W, Jones V, Kendrick T, Kessler D, Kounali D, Khan N, Lanham P, Pervin J, Peters TJ, Riozzie D, Salaminios G, Thomas L, Welton NJ, Wiles N, Woodhouse R, Lewis G. Lewis G, et al. Among authors: jones v. Lancet Psychiatry. 2019 Nov;6(11):903-914. doi: 10.1016/S2215-0366(19)30366-9. Epub 2019 Sep 19. Lancet Psychiatry. 2019. PMID: 31543474 Free PMC article. Clinical Trial.
Eosinophils in bullous pemphigoid.
Jones VA, Patel PM, Amber KT. Jones VA, et al. Panminerva Med. 2021 Sep;63(3):368-378. doi: 10.23736/S0031-0808.20.03997-X. Epub 2020 Jun 12. Panminerva Med. 2021. PMID: 32536149 Review.
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
Writing Committee for the HEALEY ALS Platform Trial; Andrews J, Paganoni S, Macklin EA, Chibnik LB, Quintana M, Saville BR, Detry MA, Vestrucci M, Marion J, McGlothlin A, Young E, Chase M, Pothier L, Harkey B, Yu H, Sherman A, Shefner J, Hall M, Kittle G, Connolly MR, Berry JD, D'Agostino D, Tustison E, Giacomelli E, Scirocco E, Alameda G, Locatelli E, Ho D, Quick A, Heitzman D, Ajroud-Driss S, Appel SH, Shroff S, Katz J, Felice K, Maragakis NJ, Simmons Z, Goutman SA, Olney N, Miller T, Fernandes JA, Ilieva H, Jawdat O, Weiss MD, Foster L, Vu T, Ladha S, Owegi MA, Newman DS, Arcila-Londono X, Jackson CE, Swenson A, Heiman-Patterson T, Caress J, Fee D, Peltier A, Lewis R, Rosenfeld J, Walk D, Johnson K, Elliott M, Kasarskis EJ, Rutkove S, McIlduff CE, Bedlack R, Elman L, Goyal NA, Rezania K, Twydell P, Benatar M, Glass J, Cohen JA, Jones V, Zilliox L, Wymer JP, Beydoun SR, Shah J, Pattee GL, Martinez-Thompson J, Nayar S, Granit V, Donohue M, Grossman K, Campbell DJ, Qureshi IA, Cudkowicz ME, Babu S. Writing Committee for the HEALEY ALS Platform Trial, et al. Among authors: jones v. JAMA Neurol. 2025 Apr;82(4):333-343. doi: 10.1001/jamaneurol.2024.5249. Epub 2025 Feb 17. JAMA Neurol. 2025. PMID: 40067754 Free PMC article. Clinical Trial.
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Luo Y, Gadd ME, Qie Y, Otamendi-Lopez A, Sanchez-Garavito JE, Brooks MM, Ulloa Navas MJ, Hundal T, Li S, Jones VK, Lou Y, Patel T, Dronca R, Kharfan-Dabaja MA, Dong H, Quinones-Hinojosa A, Qin H. Luo Y, et al. Among authors: jones vk. Mol Ther Oncol. 2024 Oct 5;32(4):200891. doi: 10.1016/j.omton.2024.200891. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39498357 Free PMC article.
995 results